J Korean Med Sci.  2000 Feb;15(1):65-67. 10.3346/jkms.2000.15.1.65.

p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women

Affiliations
  • 1Department of Microbiology, Keimyung University School of Medicine, Taegu, Korea.

Abstract

A common polymorphism of the wild type p53 is known at codon 72 of exon 4, with 2 alleles encoding either arginine (CGC, p53Arg) or proline (CCC, p53Pro). A recent study suggested that this polymorphism affects the susceptibility of p53 protein to human papillomavirus E6 oncoprotein mediated degradation and that individuals homozygous for p53Arg are seven times more susceptible to HPV-associated carcinogenesis of the cervix than heterozygotes. To examine whether the p53Arg genotype could be a risk factor for HPV-associated cervical carcinomas in the Korean population, we analyzed the p53 codon 72 polymorphism status of HPV-positive invasive cervical carcinomas from 52 Korean women and 103 healthy control samples. The proportion of individuals homozygous for p53Arg, homozygous for p53Pro, and heterozygous for the two alleles were 40%, 19%, and 41% in normal healthy controls; 42%, 17%, and 40% in women with HPV-positive invasive cervical carcinoma. There were no significant differences in the distribution of p53 genotypes between controls and cervical carcinomas. This finding indicates that the p53Arg genotype is not associated with an increased susceptibility to cervical carcinoma in Korean women.

Keyword

Genes, p53; Polymorphism (Genetics); Cervix Neoplasms; Papilomavirus

MeSH Terms

Alleles
Arginine/genetics
Cervix Neoplasms/virology
Cervix Neoplasms/genetics*
Codon/genetics*
Female
Genes, p53/genetics
Genetic Predisposition to Disease
Genotype
Human
Papillomavirus, Human/genetics
Polymerase Chain Reaction
Polymorphism (Genetics)*
Proline/genetics
Protein p53/genetics*
Risk Factors
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr